Camp Lejeune Update: Discovery in Track 1 Discovery Pool Plaintiffs has begun 

On September 26, 2023, the Court issued Case Management Order No. 2 (CMO2) and its subsequent Amendment, which provided detailed instructions, deadlines, and directives on how Camp Lejeune litigation will proceed.

The order outlined the steps the parties involved in the litigation must take, including submitting pleadings, discovery requests and other relevant documents.

Since the entry of this order, the Plaintiff’s Leadership has filed a master complaint, which is a comprehensive document that outlines the claims and allegations of all the plaintiffs involved in the litigation. The individual plaintiffs have used a short-form complaint, which is attached to CMO2, for filing purposes.

The court decided that the most efficient way to handle the litigation and resolve all claims was to stage discovery and trials by “tracks.” There are three tracks for claims: Track 1, Track 2, and Track 3.

Plaintiff’s Leadership has assembled a group of plaintiffs who may participate in “Track 1” trials. These trials involve five conditions: bladder cancer, kidney cancer, leukemia, Parkinson’s disease, and non-Hodgkin’s lymphoma.

Trials should begin in 2024 after proper discovery is conducted in accordance with CMO2.